Didier Lacombe Selected Research

human MIRN433 microRNA

5/2010

A mutation in the 3'-UTR of the HDAC6 gene abolishing the post-transcriptional regulation mediated by hsa-miR-433 is linked to a new form of dominant X-linked chondrodysplasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Didier Lacombe Research Topics

Disease

9	Fabry Disease (Fabry's Disease) 02/2022 - 07/2007
4	Neoplasms (Cancer) 01/2022 - 01/2018
4	Intellectual Disability (Idiocy) 01/2020 - 01/2008
3	Adenocarcinoma of Lung 01/2022 - 01/2020
3	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2020
3	Marfan Syndrome (Marfan's Syndrome) 01/2017 - 11/2008
3	Deafness (Deaf Mutism) 12/2016 - 11/2007
2	Hypopigmentation (Hypomelanosis) 01/2021 - 04/2006
2	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 01/2018
2	Neoplasm Metastasis (Metastasis) 01/2020 - 05/2005
2	Epilepsy (Aura) 06/2018 - 01/2017
2	Obesity 04/2017 - 08/2014
2	Hereditary Spastic Paraplegia 01/2017 - 12/2012
2	Microcephaly 12/2012 - 01/2008
2	Rubinstein-Taybi Syndrome (Syndrome, Rubinstein-Taybi) 02/2012 - 08/2007
2	Seizures (Absence Seizure) 10/2011 - 03/2008
2	Congenital Generalized Lipodystrophy (Berardinelli-Seip Congenital Lipodystrophy) 06/2010 - 08/2007
2	Insulin Resistance 06/2010 - 08/2007
2	Loeys-Dietz Syndrome 12/2009 - 11/2008
2	Infections 09/2009 - 08/2006
2	Metabolic Diseases (Metabolic Disease) 08/2007 - 07/2007
1	De Lange Syndrome (Cornelia De Lange Syndrome) 07/2022
1	Cardiomyopathies (Cardiomyopathy) 02/2022
1	Carcinogenesis 01/2022
1	Carcinoma (Carcinomatosis) 01/2021
1	Oculocutaneous Albinism (Albinism, Yellow Mutant) 01/2021
1	Cardiotoxicity 02/2020
1	Neurodevelopmental Disorders 01/2020
1	Adenocarcinoma 01/2020
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Leukoencephalopathies 01/2020
1	Neuralgia (Stump Neuralgia) 01/2019
1	Albuminuria 01/2019
1	Abdominal Pain (Pain, Abdominal) 01/2019
1	Autistic Disorder (Autism) 12/2018
1	Dowling-Degos Disease 04/2017
1	Hidradenitis Suppurativa 04/2017
1	Lactic Acidosis 01/2017
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2017
1	Agenesis of Corpus Callosum 01/2017
1	Nervous System Diseases (Neurological Disorders) 01/2017
1	Spastic ataxia Charlevoix-Saguenay type 12/2015

Drug/Important Bio-Agent (IBA)

6	EnzymesIBA 02/2022 - 01/2011
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2012
4	alpha-Galactosidase (Beano)IBA 02/2022 - 07/2007
4	Pharmaceutical PreparationsIBA 01/2021 - 10/2011
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 10/2004
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2018
3	Retinaldehyde (Retinal)IBA 01/2021 - 04/2006
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2017
3	GalactosidasesIBA 12/2019 - 01/2019
2	Nicotine FDA Link 01/2022 - 04/2017
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 12/2012
2	Biological ProductsIBA 01/2020 - 08/2014
2	Messenger RNA (mRNA)IBA 12/2018 - 05/2010
2	CREB-Binding ProteinIBA 02/2012 - 08/2007
2	Triglycerides (Triacylglycerol)IBA 06/2010 - 08/2007
2	LeptinIBA 06/2010 - 08/2007
2	Transforming Growth Factor-beta Type II ReceptorIBA 12/2009 - 11/2008
1	RNA (Ribonucleic Acid)IBA 07/2022
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 02/2022
1	GlycosphingolipidsIBA 02/2022
1	NitrosaminesIBA 01/2022
1	Superoxide DismutaseIBA 01/2022
1	AntioxidantsIBA 01/2022
1	Annexin A1IBA 01/2022
1	KetonesIBA 01/2022
1	dopachrome isomeraseIBA 01/2021
1	Mitochondrial Trifunctional ProteinIBA 01/2021
1	Trimetazidine (Vastarel)IBA 01/2021
1	5- (4- methoxyphenyl)- 3H- 1,2- dithiole- 3- thioneIBA 11/2020
1	Superoxides (Superoxide)IBA 11/2020
1	ProteomeIBA 11/2020
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 02/2020
1	Peptide Initiation Factors (Initiation Factor)IBA 01/2020
1	Eukaryotic Initiation Factor-2B (Eukaryotic Initiation Factor 2B)IBA 01/2020
1	ChromatinIBA 01/2020
1	Fragile X Mental Retardation ProteinIBA 01/2020
1	CreatinineIBA 01/2019
1	histone H3 trimethyl Lys4IBA 12/2018
1	migalastatIBA 05/2018
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	Levobupivacaine (Chirocaine)FDA Link 01/2018
1	Cytostatic AgentsIBA 01/2018
1	Oxygen (Dioxygen)IBA 01/2018
1	AntibodiesIBA 01/2018
1	Local AnestheticsIBA 01/2018
1	Keratin-5 (Keratin 5)IBA 04/2017
1	Dichlorodiphenyldichloroethane (DDD)IBA 04/2017
1	GlucosyltransferasesIBA 04/2017
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 04/2017
1	Galactoside 2-alpha-L-fucosyltransferase (Fucosyltransferase 2)IBA 04/2017
1	Fibrillin-1IBA 01/2017

Therapy/Procedure

7	Therapeutics 05/2018 - 07/2007
2	Enzyme Replacement Therapy 01/2019 - 05/2018
2	Sutures (Suture) 03/2015 - 01/2008
1	Castration 01/2020
1	Prostatectomy (Retropubic Prostatectomy) 01/2020